Article info
PDFLetter
Non-compliance: a side effect of drug information leaflets
- Correspondence to: Dr F Verdú Department of Legal Medicine, College of Medicine and Odontology, University of Valencia E G, Av/ Blasco Ibañez, n°15, 46010-Valencia (Spain); Fernando.Verduuv.es
Citation
Non-compliance: a side effect of drug information leaflets
Publication history
- First published November 30, 2004.
Online issue publication
November 30, 2004
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2004 by the Journal of Medical Ethics
Other content recommended for you
- Drug information leaflets improve parental knowledge of their child 's treatment at paediatric emergency department discharge
- Unethical informed consent caused by overlooking poorly measured nocebo effects
- Drug information at paediatric emergency department discharge: what are parents’ / patients ’ expectations
- Patients ’ adherence - related beliefs about methotrexate: a qualitative study of the role of written patient information
- What trial participants need to be told about placebo effects to give informed consent: a survey to establish existing knowledge among patients with back pain
- Towards a multilevel governance framework on the implementation of patient rights in health facilities: a protocol for a systematic scoping review
- Informed consent and clinical trials: where is the placebo effect
- Placebo effects and racial and ethnic health disparities: an unjust and underexplored connection
- Evaluation of patient rights practices in a developing country: the Edirne model for the implementation of patient rights in Turkey
- The principle of parity: the ‘ placebo effect ’ and physician communication